| 摘要: |
| 雌激素能够改善学习认知功能,防治阿尔茨海默病,但是乳腺癌、子宫内膜癌等生殖系统癌症发病率的增加限制了其临床应用。选择性雌激素受体调节剂(SERMs)是能选择性与雌激素受体结合而发挥类雌激素作用的一类非类固醇类配体,由于其对组织受体选择的特异性,从而减少了雌激素治疗的副作用。本文就近年来选择性雌激素受体调节剂发挥神经保护作用的可能机制进行综述。 |
| 关键词: 雌激素受体 选择性雌激素受体调节剂 阿尔茨海默病 |
| DOI:10.13506/j.cnki.jpr.2019.06.008 |
| 基金项目:国家自然科学基金青年项目(No.81603113);江苏省自然科学基金青年项目(No.BK20150705);中央高校基本科研业务费专项基金(No.2015PY012) |
|
|
|
| Research progress of selective estrogen receptor regulators on AD |
| REN Xiaoqian,TANG Susu,HONG Hao |
| (Department of Pharmacology,China Pharmaceutical University,Nanjing 210009, China) |
| Abstract: |
| Estrogen can improve learning and cognitive function and prevent Alzheimer's disease, but the increasing incidence of reproductive system cancers such as breast cancer and endometrial cancer limits its clinical application. Selective estrogen receptor regulators are a class of non-steroidal ligands that selectively bind to estrogen receptors and act as estrogen-like agents. Because of their specificity to tissue receptor selection, SERMs can reduce the side effects of estrogen therapy. This article reviewed the possible mechanisms of neuroprotective effects of SERMs in recent years. |
| Key words: Selective estrogen receptor modulators Estrogen receptor Alzheimer's disease |